Disease monitoring in IBD – implementation in practice

Written by Alex Burton | 12 Nov 2019 | All Medical News

Dr Maria Abreu (Miami, USA) gives us an overview of implementing disease monitoring and its challenges in clinical practice

Written by Maria Dalby

Dr Johan Burisch (Frederikssund, Denmark) gives an overview of his presentation looking at disease monitoring from a patient’s perspective, and how to increase participation

Disease monitoring in IBD – implementation in practice

Latest Stories

Liminal BioSciences announces FDA approval for its BLA of Ryplazim to treat patients with plasminogen deficiency type 1

Simple diagnostic tool predicts individual risk of Alzheimer’s

Janssen presents results of first head-to-head study of biologic therapies in patients with moderate to severe Crohn’s disease

Testosterone therapy may reduce non-alcoholic fatty liver disease in obese

Disease monitoring in IBD – implementation in practice

Latest Stories

Liminal BioSciences announces FDA approval for its BLA of Ryplazim to treat patients with plasminogen deficiency type 1

Simple diagnostic tool predicts individual risk of Alzheimer’s

Janssen presents results of first head-to-head study of biologic therapies in patients with moderate to severe Crohn’s disease

Testosterone therapy may reduce non-alcoholic fatty liver disease in obese

Register for our mailing list

Follow Us